Personalized brain stimulation to reduce negative emotions
Official title: Decoding and Modulating Affective Brain States
Run by University of Pennsylvania · NCT05437705 · Data updated 2026-11-12
This study is testing if personalized brain stimulation can help people with negative emotions like anxiety and depression feel better by targeting their specific brain patterns.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | February 21, 2023 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2029 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT05437705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are right-handed adults aged 18-65 with a PHQ-9 score of 10 or higher, indicating moderate to severe depression.
✕Probably not a fit
Patients with bipolar disorder, schizophrenia, or those who cannot tolerate TMS or MRI scans may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to create personalized brain signatures for individuals experiencing negative emotions such as rumination, major depressive disorder, and anxiety. Participants will undergo a series of MRI scans and assessments to identify their unique negative affect patterns. Following this, they will receive tailored repetitive transcranial magnetic stimulation (rTMS) sessions designed to disrupt these negative patterns. The study involves multiple visits, including behavioral tasks and assessments to evaluate the effectiveness of the stimulation protocols.
Why it matters
Potential benefit: If successful, this approach could lead to more effective treatments for individuals suffering from depression and anxiety by personalizing brain stimulation techniques.
How similar studies have gone: While the use of rTMS has been explored in other studies, this personalized approach using fMRI to tailor stimulation protocols is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. 18-65 years old 2. Patient Health Questionnaire (PHQ-9 score) = or \> than 10 3. Comprehension of instructions in the English language. 4. Capacity to provide informed consent and follow study procedures. 5. Availability for the duration of the study. Exclusion Criteria: 1. Diagnosis of bipolar disorder (as PI discretion), schizophrenia or other psychotic disorder 2. Recent use of psychoactive medications or substances as determined by investigators 3. History of neurological disorder or traumatic brain injury (other than mild) 4. Unable to have an MRI scan, or current or prior medical condition that could interfere with the collection or interpretation of MRI data 5. Unable to receive or tolerate TMS 6. Implanted devices, such as an aneurysm clip or cardiac pacemaker 7. History of stroke, epilepsy, or brain scarring 8. Pregnant, nursing, or trying to become pregnant (self-attestation alone) During this study, participants are asked to: 1. Refrain from substance use (including marijuana and illicit drugs) for duration of the study (self-attestation alone). 2. Abstain from alcohol for 24 hours before the MRI scans (self-attestation alone). 3. Abstain from increasing caffeine intake or begin taking any new medications (self-attestation alone).
Where it's running
-
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Desmond Oathes, PhD — Associate Professor of Psychiatry
- Study coordinator: Camille Blaine
- Email: camille.blaine@pennmedicine.upenn.edu
- Phone: 215-573-0828
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Readiness and Progress in Emotion Regulation Therapy
This trial will test if six modules of Emotion Regulation Therapy delivered by telehealth help adults in New York State with high worry, rumination, or self-criticism feel less anxious or depressed and function better.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
One dose of CYB003 for depression and anxiety
This study tests whether a single dose of CYB003, a psilocin-related compound, can help symptoms in adults with major depressive disorder and anxiety compared to a placebo.
-
Dupilumab for Major Depressive Disorder
This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.